ETF Holdings Breakdown of BHVN

Stock NameBiohaven Pharmaceutical Holding Co Ltd
TickerBHVN(USD) NYSE
TYPECommon Stock
CountryUSA
ISINVGG111961055
LEI5299007STZTNN32O9920

News associated with BHVN

Biohaven Ltd. (NYSE:BHVN) Receives Average Recommendation of “Buy” from Analysts
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen brokerages that are covering the company, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […] - 2025-05-01 05:12:47
Robert W. Baird Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price
Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Robert W. Baird from $60.00 to $57.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 160.39% from the […] - 2025-04-30 06:00:48
Biohaven Sees Unusually Large Options Volume (NYSE:BHVN)
Biohaven Ltd. (NYSE:BHVN – Get Free Report) saw unusually large options trading on Tuesday. Traders purchased 7,638 call options on the stock. This represents an increase of 588% compared to the typical daily volume of 1,110 call options. Biohaven Trading Up 2.7 % Shares of NYSE:BHVN opened at $21.10 on Wednesday. The company has a […] - 2025-04-23 05:28:49
Barclays PLC Has $14.67 Million Stock Position in Biohaven Ltd. (NYSE:BHVN)
Barclays PLC boosted its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 46.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 392,727 shares of the company’s stock after buying an additional 124,650 shares during the period. Barclays PLC […] - 2025-04-21 09:12:48
Summit Investment Advisors Inc. Has $336,000 Stake in Biohaven Ltd. (NYSE:BHVN)
Summit Investment Advisors Inc. increased its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 18.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,985 shares of the company’s stock after acquiring an additional 1,378 shares during the quarter. Summit Investment […] - 2025-04-21 07:56:55
Federated Hermes Inc. Trims Stock Holdings in Biohaven Ltd. (NYSE:BHVN)
Federated Hermes Inc. reduced its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,753 shares of the company’s stock after selling 8,869 shares during the quarter. Federated Hermes Inc.’s holdings […] - 2025-04-18 08:26:52
Notable Thursday Option Activity: CELH, AMD, BHVN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Celsius Holdings Inc (Symbol: CELH), where a total volume of 78,165 contracts has been traded thus far today, a contract volume which is representative of approx - 2025-04-17 19:22:18
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. reduced its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 10.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,125 shares of the company’s stock after selling 16,752 shares during the quarter. Russell Investments Group Ltd.’s holdings in Biohaven […] - 2025-04-15 09:12:54
Trexquant Investment LP Has $410,000 Position in Biohaven Ltd. (NYSE:BHVN)
Trexquant Investment LP decreased its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 10,980 shares of the company’s stock after selling 7,792 shares during the period. Trexquant Investment LP’s holdings in Biohaven were worth $410,000 at the end of the most recent […] - 2025-04-13 10:09:04
Analysts Set Biohaven Ltd. (NYSE:BHVN) Target Price at $62.77
Biohaven Ltd. (NYSE:BHVN – Get Free Report) has been assigned a consensus recommendation of “Buy” from the fifteen brokerages that are covering the firm, Marketbeat Ratings reports. Fourteen analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokerages […] - 2025-04-09 05:04:52
JPMorgan Chase & Co. Increases Position in Biohaven Ltd. (NYSE:BHVN)
JPMorgan Chase & Co. lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 144.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,979,169 shares of the company’s stock after buying an additional 1,169,721 shares during the quarter. JPMorgan Chase […] - 2025-04-04 08:55:06
Biohaven Ltd. (NYSE:BHVN) Position Increased by Vanguard Group Inc.
Vanguard Group Inc. raised its stake in Biohaven Ltd. (NYSE:BHVN – Free Report) by 8.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,414,120 shares of the company’s stock after buying an additional 628,211 shares during the period. Vanguard Group Inc. owned approximately 8.32% […] - 2025-04-04 08:04:54
KLP Kapitalforvaltning AS Makes New $601,000 Investment in Biohaven Ltd. (NYSE:BHVN)
KLP Kapitalforvaltning AS acquired a new stake in Biohaven Ltd. (NYSE:BHVN – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 16,100 shares of the company’s stock, valued at approximately $601,000. Other institutional investors and hedge funds have also recently modified their holdings of the company. Spire Wealth Management acquired a […] - 2025-04-03 08:04:51
American Century Companies Inc. Increases Stake in Biohaven Ltd. (NYSE:BHVN)
American Century Companies Inc. increased its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 9.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 558,761 shares of the company’s stock after buying an additional 48,286 shares during the period. American Century Companies Inc.’s […] - 2025-03-31 07:48:50
8,037 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Cibc World Markets Corp
Cibc World Markets Corp purchased a new stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 8,037 shares of the company’s stock, valued at approximately $300,000. A number of other large investors have also […] - 2025-03-25 08:16:54
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Swiss National Bank
Swiss National Bank raised its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 12.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 154,800 shares of the company’s stock after buying an additional 16,800 shares during the period. Swiss National Bank’s holdings in Biohaven were worth $5,782,000 at the end […] - 2025-03-24 08:32:57
Victory Capital Management Inc. Has $13.36 Million Stake in Biohaven Ltd. (NYSE:BHVN)
Victory Capital Management Inc. trimmed its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 357,765 shares of the company’s stock after selling 5,850 shares during the […] - 2025-03-13 08:32:52
Morgan Stanley Cuts Biohaven (NYSE:BHVN) Price Target to $63.00
Biohaven (NYSE:BHVN – Free Report) had its price objective lowered by Morgan Stanley from $69.00 to $63.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research analysts also recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating on […] - 2025-03-10 05:37:44
Biohaven (NYSE:BHVN) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $54.00 price target on the stock. Several other equities analysts also recently commented on BHVN. Cantor Fitzgerald reiterated an “overweight” rating on shares of Biohaven in a report on […] - 2025-03-05 08:45:00
Biohaven Ltd. (NYSE:BHVN) Shares Purchased by Principal Financial Group Inc.
Principal Financial Group Inc. raised its holdings in Biohaven Ltd. (NYSE:BHVN – Free Report) by 4.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 77,387 shares of the company’s stock after acquiring an additional 3,281 shares during the period. Principal Financial Group Inc.’s holdings in Biohaven […] - 2025-03-05 08:12:49
Biohaven (NYSE:BHVN) Trading Down 6.1% After Earnings Miss
Biohaven Ltd. (NYSE:BHVN – Get Free Report) fell 6.1% during mid-day trading on Monday after the company announced weaker than expected quarterly earnings. The company traded as low as $34.27 and last traded at $34.91. 385,353 shares were traded during mid-day trading, a decline of 55% from the average session volume of 853,036 shares. The […] - 2025-03-05 06:34:52
Handelsbanken Fonder AB Raises Stock Holdings in Biohaven Ltd. (NYSE:BHVN)
Handelsbanken Fonder AB boosted its stake in Biohaven Ltd. (NYSE:BHVN – Free Report) by 20.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,000 shares of the company’s stock after buying an additional 4,300 shares during the period. Handelsbanken Fonder AB’s […] - 2025-02-28 09:28:56
Short Interest in Biohaven Ltd. (NYSE:BHVN) Drops By 5.0%
Biohaven Ltd. (NYSE:BHVN – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 9,440,000 shares, a decline of 5.0% from the January 15th total of 9,940,000 shares. Based on an average trading volume of 972,100 shares, the short-interest ratio is […] - 2025-02-19 08:59:31
Brokerages Set Biohaven Ltd. (NYSE:BHVN) Target Price at $63.15
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have received an average rating of “Buy” from the fifteen brokerages that are covering the company, MarketBeat Ratings reports. Fourteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target […] - 2025-02-18 06:13:02
Spire Wealth Management Acquires Shares of 1,500 Biohaven Ltd. (NYSE:BHVN)
Spire Wealth Management bought a new position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,500 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds and other institutional investors […] - 2025-02-10 18:38:57

BHVN institutional holdings

The following institutional investment holdings of BHVN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 54,906USD 1,111,847
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 52,181USD 1,056,665 6.1%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,503USD 30,436
Total =108,590 USD 2,198,948
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.